Abstract

Porcine cysticercosis, human taeniasis, and (neuro)cysticercosis are endemic in many low- and middle-income countries (LMIC) where they present a significant health burden to affected communities. Neurocysticercosis (NCC) is one of the leading causes of human epilepsy in many hyperendemic regions in Latin America, Asia, and sub-Saharan Africa. The World Health Organization (WHO) reports an estimated 2.5–8.3 million cases of NCC annually with a disability-adjusted life year (DALY) burden of 2.8 million, but as for all neglected tropical diseases (NTDs), these values are likely to be underestimated. Diagnosis of NCC is complex and most accurately diagnosed using clinical neuroimaging that is unavailable in most hyperendemic regions in LMIC. On January 28, 2021, WHO will launch its road map for the NTDs' “Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030.” Taeniasis/cysticercosis is targeted for control success considered as steady increase in the number of countries with intensified control in hyperendemic areas [increasing from 2 (3%) in 2020 to 4 (6%) in 2023, to 9 (14%) by 2025, and to 17 (27%) by 2030]. Cross-cutting targets that include 100% access to at least basic water supply, sanitation, and hygiene in areas endemic for NTDs and 75% integrated treatment coverage for preventative chemotherapy will additionally impact on the taeniasis/cysticercosis/NCC complex. With no vaccine available for humans, prevention of infection depends on communication to the public of the life cycle of a complex zoonosis to promote behavior change, underpinned by practical control measures including treatment of human taeniasis and (neuro)cysticercosis with albendazole and praziquantel [widely used as part of the mass drug administration (MDA) deworming programs], surgery where appropriate, and effective vaccination and deworming for pigs supported by meat inspection. Here, we review recent advances in tools and implementation for Taenia solium taeniasis/(neuro)cysticercosis (TSTC) control and milestones on the onward path to elimination.

Highlights

  • Taeniasis andcysticercosis are caused by the cestode Taenia solium or pork tapeworm

  • NCC is a major clinical consequence of T. solium infection and the dominant cause of global preventable epilepsy associated with morbidity and mortality from epileptic seizures and epilepsy related death; where T. solium is endemic, 30% of epilepsy cases are estimated to be caused by NCC [3, 4]

  • computed tomography (CT) scanning is the most common imaging tool used for diagnosis, especially in developing countries; CT is less effective than Magnetic resonance imaging (MRI) at identifying intraventricular cysts, which comprise up to 22% of all NCC cases [35, 36]

Read more

Summary

INTRODUCTION

Taeniasis and (neuro)cysticercosis are caused by the cestode Taenia solium or pork tapeworm. T. solium infection arises from ingestion of contaminated food or water and ingestion of raw or undercooked pork and may result in taeniasis (caused by the adult tapeworm living in the small intestine) and/or cysticercosis or neurocysticercosis [NCC; caused by invasion of the larvae into the central nervous system (CNS)] in humans. In cases of NCC, T. solium larvae are found either in the brain tissue (parenchymal NCC) or in the intraventricular and subarachnoid spaces of the brain and spinal cord where the cerebrospinal fluid (CSF) circulates (extraparenchymal NCC) resulting in different clinical manifestations and prognoses. A definitive clinical diagnosis is only made by visualization of cysts or larvae in the brain tissue via neuroimaging [15,16,17]; in some cases, intracranial calcification of cysts is the only evidence of the disease [5]. Definitive classifications have been provided by Del Brutto et al [20], revised in 2017 (Table 1), and Carpio et al (Table 2) [20,21,22]

Serological Diagnostic Tests
Complications of Chemotherapy
Avoidance of Drug Resistance
Treatment frequency
Vaccination and Cysticidal Drugs for Pigs
Meat Inspection
Communication and Health Messaging
Findings
AUTHOR CONTRIBUTIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call